drugset / Trial / NCT06152471
Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
The present study aims to investigate a proactive strategy including Salovum™ and SPC-flakes to prevent the occurrence of abemaciclib-induced diarrhea in patients with early breast cancer.
Timeline
- Start
- 2023-06-07
- Primary completion
- 2024-10-31
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPC-flakes | Unknown | 75 g | — |
| Subject | Salovum | Unknown | 16 g | — |